Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PhytoMedical signs letter of intent with Medicilon for studies on brain cancer drug candidate

April 19, 2010

Celgene and Agios collaborate to develop cancer metabolism programs

April 19, 2010

AD5-10: new option for treatment of ovarian cancer

April 19, 2010

University of Central Florida claims new STAT3 inhibitors

April 19, 2010

Angiochem's EPiC platform yields anticancer drugs with improved brain penetration

April 19, 2010

Aveo receives milestone payment from Biogen Idec for erbB-3 antibody program

April 16, 2010

EntreMed begins phase II ENMD-981693 trial in ovarian cancer

April 16, 2010

Aeterna Zentaris receives advice from the EMA for phase III perifosine program

April 16, 2010

Roche to submit marketing application to FDA for trastuzumab-DM1 in breast cancer

April 16, 2010

Equispharm claims new kinase B-raf inhibitors

April 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...